U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Pediatric Product Development
  1. Development Resources

Pediatric Product Development

Many of FDA's initiatives around pediatrics have aimed to improve medical product research in children. This is making for safer and more effective treatments.  For further information about pediatric product development, please contact pedsdrugs@fda.hhs.gov or 301-796-2200.


Contact DPMH

Food and Drug Administration
Center for Drug Evaluation and Research
Office of New Drugs
10903 New Hampshire Avenue
Silver Spring, MD 20993
Main Line: 301-796-2200   
Fax: 301-796-9744

Back to Top